Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy - PubMed (original) (raw)

doi: 10.1016/j.hrthm.2011.10.016. Epub 2011 Oct 17.

Steven A Lubitz, Seiko Makino, Zahid Islam, J Michael Frangiskakis, Haider Mehdi, Rebecca Gutmann, Michael L Zhang, Heather L Bloom, Calum A MacRae, Samuel C Dudley, Alaa A Shalaby, Raul Weiss, Dennis M McNamara, Barry London, Patrick T Ellinor

Affiliations

Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy

Marwan M Refaat et al. Heart Rhythm. 2012 Mar.

Abstract

Background: Dilated cardiomyopathy (DCM) is a leading cause of heart failure and death. The etiology of DCM is genetically heterogeneous.

Objectives: We sought to define the prevalence of mutations in the RNA splicing protein RBM20 in a large cohort with DCM and to determine whether genetic variation in RBM20 is associated with clinical outcomes.

Methods: Subjects included in the Genetic Risk Assessment of Defibrillator Events (GRADE) study were aged at least 18 years, had an ejection fraction of ≤30%, and an implantable cardioverter-defibrillator (ICD). The coding region and splice junctions of RBM20 were screened in subjects with DCM; 2 common polymorphisms in RBM20, rs942077 and rs35141404, were genotyped in all GRADE subjects.

Results: A total of 1465 subjects were enrolled in the GRADE study, and 283 with DCM were screened for RBM20 mutations. The mean age of subjects with DCM was 58 ± 13 years, 64% were males, and the mean follow-up time was 24.2 ± 17.1 months after ICD placement. RBM20 mutations were identified in 8 subjects with DCM (2.8%). Mutation carriers had a similar survival, transplantation rate, and frequency of ICD therapy compared with nonmutation carriers. Three of 8 subjects with RBM20 mutations (37.5%) had atrial fibrillation (AF), whereas 19 subjects without mutations (7.4%) had AF (P = .02). Among all GRADE subjects, rs35141404 was associated with AF (minor allele odds ratio = 0.62; 95% confidence interval = 0.44-0.86; P = .006). In the subset of GRADE subjects with DCM, rs35141404 was associated with AF (minor allele odds ratio = 0.58; P = .047).

Conclusions: Mutations in RBM20 were observed in approximately 3% of subjects with DCM. There were no differences in survival, transplantation rate, and frequency of ICD therapy in mutation carriers.

Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Topology and location of RBM20 mutations in GRADE subjects with dilated cardiomyopathy.

Figure 2

Figure 2

Outcomes in RBM20 mutation carriers with DCM. A. Kaplan-Meier plots for freedom from appropriate ICD shocks in DCM subjects with or without a mutation in RBM20 after 36 months of follow-up. B. Kaplan-Meier plots for survival in DCM subjects with or without a mutation in RBM20 after 36 months of follow-up. None of the comparisons were statistically significant.

Figure 3

Figure 3

Relation between outcomes in the entire GRADE cohort and SNPs rs35141404 or rs942077. Kaplan-Meier plots for freedom from appropriate ICD shocks in the entire GRADE cohort after 60 months of follow-up for rs35141404 (A) or rs942077 (C). Kaplan-Meier plots for survival in the entire GRADE cohort after 60 months of follow-up in rs35141404 (B) or rs942077 (D). None of the comparisons were statistically significant.

Comment in

Similar articles

Cited by

References

    1. Codd MB, Sugrue DD, Gersh BJ, Melton LJ., 3rd Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in olmsted county, minnesota, 1975–1984. Circulation. 1989;80:564–572. - PubMed
    1. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47:525–531. - PubMed
    1. Michels VV, Driscoll DJ, Miller FA, et al. Progression of familial and non-familial dilated cardiomyopathy: Long term follow up. Heart. 2003;89:757–761. - PMC - PubMed
    1. Sugrue DD, Rodeheffer RJ, Codd MB, Ballard DJ, Fuster V, Gersh BJ. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med. 1992;117:117–123. - PubMed
    1. Bioerck G, Orinius E. Familial cardiomyopathies. Acta Med Scand. 1964;176:407–424. - PubMed

MeSH terms

Substances

Grants and funding

LinkOut - more resources